Shirofune Releases Expanded Improvement Suggestion Feature for Amazon Ads
22 juil. 2024 08h00 HE
|
Shirofune
EL SEGUNDO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Shirofune, the leading digital advertising automation management tool, today announced an enhanced Improvement Suggestion feature that proposes...
Mobilicom Announces Receipt of Nasdaq Minimum Bid Price Notification
28 juin 2024 16h15 HE
|
Mobilicom Limited
Shoham, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics,...
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
07 févr. 2024 08h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Closing of $15 Million Public Offering
06 févr. 2024 08h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Semcasting Launches Real-Time Voter Measurement Feature in AudienceDesigner for Political Advertisers
05 févr. 2024 09h00 HE
|
Semcasting
Semcasting launches Real-Time Voter Measurement (RTVM), a new voter transparency feature in AudienceDesigner (ADS)
Evaxion Biotech Announces Pricing of $15 Million Public Offering
01 févr. 2024 09h20 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Completion of ADS Ratio Change
22 janv. 2024 16h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Evaxion Announces Plan to Implement ADS Ratio Change
08 janv. 2024 08h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
Global Automatic Dependent Surveillance Broadcast (ADS-B) Strategic Analysis Report 2023: Market to Reach $2.8 Billion by 2030 - Sustained Emphasis on Improving Aircraft Safety
04 déc. 2023 09h18 HE
|
Research and Markets
Dublin, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The "Automatic Dependent Surveillance Broadcast (ADS-B) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
SaverOne Announces Receipt of Nasdaq Minimum Bid Price Notification
27 oct. 2023 16h05 HE
|
SaverOne 2014 Ltd.
Petah Tikvah, Israel, Oct. 27, 2023 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company specializing in transportation safety solutions, announced today that on...